Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 561.30M | 586.50M | 622.20M | 594.30M | 398.60M |
Gross Profit | 249.70M | 245.80M | 247.60M | 239.00M | 156.10M |
EBITDA | 107.20M | 102.00M | 92.00M | 104.20M | 57.90M |
Net Income | 33.50M | 38.50M | 36.50M | 41.00M | 18.50M |
Balance Sheet | |||||
Total Assets | 993.00M | 978.80M | 1.03B | 1.03B | 699.80M |
Cash, Cash Equivalents and Short-Term Investments | 43.60M | 17.00M | 50.00M | 52.30M | 44.10M |
Total Debt | 172.80M | 166.30M | 216.20M | 218.00M | 71.80M |
Total Liabilities | 350.00M | 342.20M | 401.10M | 408.30M | 198.90M |
Stockholders Equity | 643.00M | 636.60M | 627.10M | 617.70M | 500.90M |
Cash Flow | |||||
Free Cash Flow | 79.50M | 63.10M | 43.10M | 40.30M | 28.20M |
Operating Cash Flow | 105.10M | 97.60M | 86.90M | 74.90M | 53.30M |
Investing Cash Flow | -27.90M | -28.50M | -44.00M | -270.50M | -26.30M |
Financing Cash Flow | -50.60M | -102.10M | -45.20M | 203.90M | -30.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £144.82M | 9.11 | 16.03% | 4.32% | -6.20% | 83.31% | |
76 Outperform | £1.17B | 29.56 | 16.36% | 1.62% | 7.32% | -6.70% | |
76 Outperform | £248.80M | 70.84 | 1.63% | 5.04% | -10.36% | -41.41% | |
74 Outperform | £157.94M | 15.82 | 9.56% | 3.67% | -1.81% | 15.19% | |
71 Outperform | ¥255.26B | 12.93 | 8.49% | 3.09% | 6.31% | 12.94% | |
70 Outperform | £994.61M | 29.64 | 5.24% | 4.11% | -4.30% | -13.09% | |
69 Neutral | £1.32B | ― | -2.02% | 2.20% | -5.23% | -301.98% |
Genuit Group plc announced that Martin Gisbourne, the Chief Strategy and Sustainability Officer, exercised a nil-cost option over 2,165 shares as part of a Long-Term Incentive Plan awarded in April 2022. This transaction, compliant with UK Market Abuse Regulation, involved selling sufficient shares to cover tax and national insurance liabilities, reflecting a strategic financial decision within the company’s executive management.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc announced a board change, with Louise Brooke-Smith stepping down as Non-Executive Director and designated Employee Engagement Non-Executive Director after six years of service. Bronagh Kennedy, a current Non-Executive Director, will assume the role of designated Employee Engagement Non-Executive Director effective 24 September 2025. This change aligns with the company’s governance practices and may impact its employee engagement strategies.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group PLC, a company involved in the manufacturing sector, announced the successful passing of all resolutions during its Annual General Meeting held on May 19, 2025. The resolutions included the approval of audited accounts, directors’ remuneration, the declaration of a final dividend, re-election of directors, and authorization for share allotment and market purchases. The outcomes reflect strong shareholder support, which may positively impact the company’s governance and strategic initiatives.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc has reported that its trading for the first four months of 2025 is in line with expectations, with an 8.5% increase in revenue compared to the previous year. The company has seen organic sales growth across its business units and has gained market share despite a competitive environment. Genuit is focusing on productivity improvements through the Genuit Business System and is well-positioned to navigate current economic uncertainties. The company remains confident in its ability to outperform the market over the medium term due to its strong focus on sustainability-linked growth drivers.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc has published its 2024 Annual Report and Accounts and announced the 2025 Annual General Meeting, scheduled for May 19, 2025, in Leeds. This announcement underscores Genuit’s commitment to transparency and stakeholder engagement, as it continues to focus on sustainable solutions in the built environment sector.
Genuit Group plc has announced the granting of awards under its 2024 Long Term Incentive Plan to key directors and senior management, including the CEO and CFO. These awards, structured as nil-cost options, are contingent upon achieving specific performance conditions related to cash conversion, earnings per share growth, and sustainability targets over a three-year period. The performance conditions are designed to align with the company’s strategic objectives, including its sustainability strategy. The awards aim to incentivize management to drive long-term shareholder value and enhance the company’s competitive positioning in the market.
Genuit Group plc announced the granting of awards under its 2024 Deferred Share Bonus Plan to key executives, including CEO Joe Vorih and CFO Tim Pullen. These awards, structured as nil-cost options, are part of the company’s remuneration policy and are exercisable over a ten-year period, with vesting dates in 2027 and 2028. This move is in line with the company’s strategy to align executive compensation with shareholder interests and reflects a commitment to long-term value creation.